Tameside Hospital NHS Foundation Trust Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2003
NCT00902616
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Tameside Hospital NHS Foundation Trust

Active Ingredients

Drugs in Phase 4 Trials (4)

arginine (1 trial)

isosorbide (isordil) (1 trial)

testosterone (delatestryl) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Neuropathies (Phase 4)

Hypogonadism (Phase 4)

Peripheral Nervous System Diseases (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4